Explore
Trendline
Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast
Exelixis to Announce Q1 2026 Financial Results with Conference Call and Webcast
Read More
Trendline
Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates
Zai Lab to Announce First Quarter 2026 Financial Results and Corporate Updates
Read More
Trendline
Gilead Sciences to Announce Q1 2026 Financial Results with Business Update
Gilead Sciences to Announce Q1 2026 Financial Results with Business Update
Read More
Trendline
Boston Scientific Reports Strong Q1 2026 Financial Results with Significant Sales Growth
Boston Scientific Reports Strong Q1 2026 Financial Results with Significant Sales Growth
Read More
Trendline
Xeris Biopharma to Announce Q1 2026 Financial Results with Upcoming Conference Call
Xeris Biopharma to Announce Q1 2026 Financial Results with Upcoming Conference Call
Read More
Trendline
Vir Biotechnology Announces Upcoming Conference Call to Discuss Q1 2026 Financial Results
Vir Biotechnology Announces Upcoming Conference Call to Discuss Q1 2026 Financial Results
Read More
Trendline
Sartorius Stedim Biotech Reports Strong Q1 2026 Financial Results
Sartorius Stedim Biotech Reports Strong Q1 2026 Financial Results
Read More
Trendline
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Pfizer Presents Oncology Innovations at ASCO 2026, Highlighting New Cancer Treatment Strategies
Read More
Trendline
Schrödinger to Announce First Quarter 2026 Financial Results, Impacting Investors
Schrödinger to Announce First Quarter 2026 Financial Results, Impacting Investors
Read More
Trendline
OmniAb to Announce First Quarter 2026 Financial Results in Upcoming Conference Call
OmniAb to Announce First Quarter 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call
Maravai LifeSciences to Announce Q1 2026 Financial Results in Upcoming Conference Call
Read More
Trendline
Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments
Arrowhead Pharmaceuticals Anticipates Further Stock Gains Amid Clinical Trial Developments
Read More
